While the drugs have grown in popularity among doctors and patients, they are generally too expensive for most people to ...

Novo Nordisk remains financially strong, but pricing pressures and CagriSema challenges limit near-term upside. Find out why ...

The secret of the president’s dramatic weight loss is the talk of the White House, our must-read newsletter The Swamp reveals.

Our writer shows how investing regularly in a SIPP account can lead to a £1m+ portfolio for savvy investors who start early ...

A few Easter eggs too many have stopped your weight-loss goals in their tracks, but don’t allow that to cause your motivation ...

Novo Nordisk has said it is discontinuing selling its popular, best-selling insulin brand in India and will instead promote ...